<h4>Objectives</h4>Vascular endothelial growth factor receptor 2 (VEGFR2) is a critical therapeutic target in hepatocellular carcinoma (HCC) due to its role in angiogenesis and tumor progression. This evidence concerns the gene KDR and neoplasm.